Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 229

1.

Ionophoric polyphenols selectively bind Cu2+, display potent antioxidant and anti-amyloidogenic properties, and are non-toxic toward Tetrahymena thermophila.

Martínez A, Alcendor R, Rahman T, Podgorny M, Sanogo I, McCurdy R.

Bioorg Med Chem. 2016 Jun 5. pii: S0968-0896(16)30435-7. doi: 10.1016/j.bmc.2016.06.012. [Epub ahead of print]

PMID:
27316544
2.

The central role of heat shock factor 1 in synaptic fidelity and memory consolidation.

Hooper PL, Durham HD, Török Z, Hooper PL, Crul T, Vígh L.

Cell Stress Chaperones. 2016 Jun 9. [Epub ahead of print]

PMID:
27283588
3.

Caloric restriction: beneficial effects on brain aging and Alzheimer's disease.

Van Cauwenberghe C, Vandendriessche C, Libert C, Vandenbroucke RE.

Mamm Genome. 2016 May 30. [Epub ahead of print] Review.

PMID:
27240590
4.

Mood, stress and longevity: convergence on ANK3.

Rangaraju S, Levey DF, Nho K, Jain N, Andrews KD, Le-Niculescu H, Salomon DR, Saykin AJ, Petrascheck M, Niculescu AB.

Mol Psychiatry. 2016 May 24. doi: 10.1038/mp.2016.65. [Epub ahead of print]

PMID:
27217151
5.

Intrahippocampal Administration of Ibotenic Acid Induced Cholinergic Dysfunction via NR2A/NR2B Expression: Implications of Resveratrol against Alzheimer Disease Pathophysiology.

Karthick C, Periyasamy S, Jayachandran KS, Anusuyadevi M.

Front Mol Neurosci. 2016 Apr 26;9:28. doi: 10.3389/fnmol.2016.00028. eCollection 2016.

6.

The Use of Stilbene Scaffold in Medicinal Chemistry and Multi-Target Drug Design.

Giacomini E, Rupiani S, Guidotti L, Recanatini M, Roberti M.

Curr Med Chem. 2016 May 17. [Epub ahead of print]

PMID:
27183980
7.
8.

Improved Neuroprotection Provided by Drug Combination in Neurons Exposed to Cell-Derived Soluble Amyloid-β Peptide.

Colin J, Allouche A, Chauveau F, Corbier C, Pauron-Gregory L, Lanhers MC, Claudepierre T, Yen FT, Oster T, Malaplate-Armand C.

J Alzheimers Dis. 2016 May 7;52(3):975-87. doi: 10.3233/JAD-151110.

PMID:
27163806
9.

The combination of 1α,25dihydroxyvitaminD3 with resveratrol improves neuronal degeneration by regulating endoplasmic reticulum stress, insulin signaling and inhibiting tau hyperphosphorylation in SH-SY5Y cells.

Cheng J, Xia X, Rui Y, Zhang Z, Qin L, Han S, Wan Z.

Food Chem Toxicol. 2016 Jul;93:32-40. doi: 10.1016/j.fct.2016.04.021. Epub 2016 Apr 28.

PMID:
27133915
10.

Protective effects of resveratrol on aging-induced cognitive impairment in rats.

Gocmez SS, Gacar N, Utkan T, Gacar G, Scarpace PJ, Tumer N.

Neurobiol Learn Mem. 2016 May;131:131-6. doi: 10.1016/j.nlm.2016.03.022. Epub 2016 Mar 31.

PMID:
27040098
11.

Resveratrol and Alzheimer's Disease: Mechanistic Insights.

Ahmed T, Javed S, Javed S, Tariq A, Šamec D, Tejada S, Nabavi SF, Braidy N, Nabavi SM.

Mol Neurobiol. 2016 Mar 19. [Epub ahead of print] Review.

PMID:
26993301
12.

The effect of resveratrol on beta amyloid-induced memory impairment involves inhibition of phosphodiesterase-4 related signaling.

Wang G, Chen L, Pan X, Chen J, Wang L, Wang W, Cheng R, Wu F, Feng X, Yu Y, Zhang HT, O'Donnell JM, Xu Y.

Oncotarget. 2016 Mar 13. doi: 10.18632/oncotarget.8041. [Epub ahead of print]

13.

Oncostatic-Cytoprotective Effect of Melatonin and Other Bioactive Molecules: A Common Target in Mitochondrial Respiration.

Pacini N, Borziani F.

Int J Mol Sci. 2016 Mar 7;17(3). pii: E341. doi: 10.3390/ijms17030341. Review.

14.

Comparison of the effects of resveratrol and caloric restriction on learning and memory in juvenile C57BL/6J mice.

Xu BL, Wang R, Ma LN, Dong W, Zhao ZW, Zhang JS, Wang YL, Zhang X.

Iran J Basic Med Sci. 2015 Nov;18(11):1118-23.

15.

Resveratrol as a Potential Therapeutic Candidate for the Treatment and Management of Alzheimer's Disease.

Braidy N, Jugder BE, Poljak A, Jayasena T, Mansour H, Nabavi SM, Sachdev P, Grant R.

Curr Top Med Chem. 2016;16(17):1951-60.

PMID:
26845555
16.

Neuroprotective Role of Natural Polyphenols.

Spagnuolo C, Napolitano M, Tedesco I, Moccia S, Milito A, Russo GL.

Curr Top Med Chem. 2016;16(17):1943-50.

PMID:
26845551
17.

Pharmacological activities and structure-modification of resveratrol analogues.

Xiao Y, Chen H, Song C, Zeng X, Zheng Q, Zhang Y, Lei X, Zheng X.

Pharmazie. 2015 Dec;70(12):765-71.

PMID:
26817272
18.

Alzheimer's disease: An overview of amyloid beta dependent pathogenesis and its therapeutic implications along with in silico approaches emphasizing the role of natural products.

Awasthi M, Singh S, Pandey VP, Dwivedi UN.

J Neurol Sci. 2016 Feb 15;361:256-71. doi: 10.1016/j.jns.2016.01.008. Epub 2016 Jan 8. Review.

PMID:
26810552
19.

Chronic administration of resveratrol prevents morphological changes in prefrontal cortex and hippocampus of aged rats.

Monserrat Hernández-Hernández E, Serrano-García C, Antonio Vázquez-Roque R, Díaz A, Monroy E, Rodríguez-Moreno A, Florán B, Flores G.

Synapse. 2016 May;70(5):206-17. doi: 10.1002/syn.21888. Epub 2016 Feb 19.

PMID:
26789275
20.

Metal chelation, radical scavenging and inhibition of Aβ₄₂ fibrillation by food constituents in relation to Alzheimer's disease.

Chan S, Kantham S, Rao VM, Palanivelu MK, Pham HL, Shaw PN, McGeary RP, Ross BP.

Food Chem. 2016 May 15;199:185-94. doi: 10.1016/j.foodchem.2015.11.118. Epub 2015 Nov 26.

PMID:
26775960
Items per page

Supplemental Content

Loading ...
Write to the Help Desk